AllianceBernstein’s Morphic Holding, Inc. Common Stock MORF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-150,558
| Closed | -$5.13M | – | 3282 |
|
|
2024
Q2 | $5.13M | Buy |
150,558
+38,776
| +35% | +$1.15M | ﹤0.01% | 1478 |
|
|
2024
Q1 | $3.93M | Sell |
111,782
-97,394
| -47% | -$3.26M | ﹤0.01% | 1563 |
|
|
2023
Q4 | $6.04M | Buy |
209,176
+167,606
| +403% | +$3.99M | ﹤0.01% | 1413 |
|
|
2023
Q3 | $952K | Sell |
41,570
-1,119,047
| -96% | -$58.7M | ﹤0.01% | 2274 |
|
|
2023
Q2 | $66.5M | Buy |
1,160,617
+1,096,832
| +1,720% | +$57.3M | 0.03% | 496 |
|
|
2023
Q1 | $2.4M | Sell |
63,785
-3,947
| -6% | -$145K | ﹤0.01% | 1766 |
|
|
2022
Q4 | $1.81M | Buy |
67,732
+15,753
| +30% | +$431K | ﹤0.01% | 1978 |
|
|
2022
Q3 | $1.47M | Sell |
51,979
-33,863
| -39% | -$944K | ﹤0.01% | 2084 |
|
|
2022
Q2 | $1.86M | Buy |
85,842
+40,708
| +90% | +$1.14M | ﹤0.01% | 1995 |
|
|
2022
Q1 | $1.81M | Buy |
45,134
+22,434
| +99% | +$939K | ﹤0.01% | 2147 |
|
|
2021
Q4 | $1.08M | Sell |
22,700
-600
| -3% | -$32.2K | ﹤0.01% | 2440 |
|
|
2021
Q3 | $1.32M | Hold |
23,300
| – | – | ﹤0.01% | 2391 |
|
|
2021
Q2 | $1.34M | Buy |
23,300
+9,700
| +71% | +$534K | ﹤0.01% | 2405 |
|
|
2021
Q1 | $861K | Sell |
13,600
-3,600
| -21% | -$165K | ﹤0.01% | 2472 |
|
|
2020
Q4 | $577K | Sell |
17,200
-100
| -0.6% | -$2.96K | ﹤0.01% | 2526 |
|
|
2020
Q3 | $473K | Sell |
17,300
-1,100
| -6% | -$28.8K | ﹤0.01% | 2556 |
|
|
2020
Q2 | $498K | Buy |
18,400
+7,900
| +75% | +$148K | ﹤0.01% | 2613 |
|
|
2020
Q1 | $154K | Buy |
+10,500
| New | +$176K | ﹤0.01% | 2865 |
|
Other funds holding MORF
AllianceBernstein's MORF Position: Q3 2024 in Review
AllianceBernstein sold out of Morphic Holding, Inc. Common Stock (MORF) in Q3 2024, closing a stake of 150,558 shares — an estimated $5.13M sold.
AllianceBernstein first reported a position in MORF in Q1 2020 and held it in 18 quarters. The position peaked at $66.5M in Q2 2023. 2 funds tracked by Wall St. Rank hold MORF as of Q3 2024.
- AllianceBernstein reported no remaining Morphic Holding, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- AllianceBernstein sold 150,558 Morphic Holding, Inc. Common Stock shares in Q3 2024, an estimated $5.13M.
- AllianceBernstein first reported a position in Morphic Holding, Inc. Common Stock in Q1 2020 and held it in 18 quarters.
- AllianceBernstein's Morphic Holding, Inc. Common Stock position peaked at $66.5M in Q2 2023.
- 2 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q3 2024.
Based on AllianceBernstein's 13F filing for Q3 2024, filed 14 Nov 2024.